Markets
Integrated solutions for GLP-1 and peptides
Supporting the growth of GLP-1 and peptide therapies
The rapid growth of GLP-1 and peptide-based therapies is reshaping the pharmaceutical landscape, driven by increasing demand for treatments in diabetes, obesity, and other chronic conditions. As these biologic molecules move toward large-scale adoption, pharmaceutical companies need reliable partners able to support product development, industrialization, and commercial supply. Stevanato Group responds to this evolving market with integrated solutions for GLP-1 and peptides, combining primary packaging, drug delivery devices, assembly equipment, and analytical services to help pharma partners bring safe, scalable, and patient-centric therapies to market.
key-challenges
Key factors to consider include:
-
Supply chain security
Significant demand puts pressure on global supply chains, making reliable production and supply continuity essential. -
RTU primary packaging availability
Ready-to-Use primary packaging is critical to ensure clinical supplies and support commercial scale-up. -
Risk mitigation from development to commercialization
Early assessment of drug containers, device specifications, and process requirements helps reduce risk across the product lifecycle. -
Time to market
Speed is a key variable to seize market opportunities in the rapidly growing GLP-1 and peptide therapy space. -
Drug product wastage
Minimizing drug product loss is essential, particularly for high-value biologic molecules. -
Patient preferences
Pen injectors and autoinjectors - offering fixed or variable dosing and single or multiple injections - can address diverse patient preferences across geographies
integrated-offering
Explore our solutions for GLP-1 and peptides
Stevanato Group supports GLP-1 and peptide production processes with a comprehensive offering across the pharma value chain. Explore our solutions for primary packaging, drug delivery devices, visual inspection, assembly technologies, and analytical services.
our-solutions
Our Solutions
Analytical Services
Our Technology Excellence Centers (TEC) manages customer requests throughout the design and development process by providing phase-appropriate testing for containers and devices.
EZ-fill® Nexa Syringes
High-performance syringe systems ensure consistent performance with drug delivery devices
EZ-fill® Nexa Cartridges
Designed for optimizing the fill and finish process and the performance with drug delivery systems
Aidaptus®
2-step, single use auto-injector accommodating both 1mL and 2.25 mL prefilled glass syringes in the same base device.
Alina®
Alina® user-friendly disposable pen injector platform for variable and multi-dose treatments for weight management and diabetes care
white-paper-and-article